Investments

Co-Investment
Held / Exited
  • GBA-LOGO
    Co-Investment

    GBA Group

    Germany

    Healthcare & life science
    Healthcare & life science

    GBA Group is a leading independent provider of highest-quality bio-analytical laboratory services for food, environment, and pharmaceutical testing. The group focuses on tailor-made solutions to meet its clients’ needs, backed by its strong scientific expertise, very comprehensive service portfolio as well as continuous dialogue with its customers. Headquartered in Hamburg, GBA employs well over 1,000 employees and operates more than 40 labs across central Europe.

  • Logo Waterlogic
    Co-Investment

    Waterlogic

    United-KIngdom

    Business services
    Business services

    Founded in 1992 in the UK, Waterlogic was one of the pioneers of the point-of-use water dispensing systems operating across more than 50 countries and with best-in-class proprietary technology. It is the clear #1 provider of purified drinking water dispensers for the workplace, hospitals, schools, hotels and restaurants. The company has evolved from a manufacturer with a main revenue stream from units' sale to a vertically integrated service company with a full service rental business model.

  •  Groupe-La-Centrale
    Co-Investment

    Groupe La Centrale

    France

    Technology, Media and Telecom
    Technology, Media and Telecom

    Founded in 1969, as a newspaper (today only digital), Groupe La Centrale is the French #2 car marketplace, behind Leboncoin. It serves as a one-stop-shop for car dealers and prospective buyers through its portals for both used and new cars sales from car dealers, and the one for C2B used car sales to car dealers. Headquartered in Paris, it employs 200 people and 35 freelancers.

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA